Relationships between the changes of serum levels of OPG and RANKL with age, menopause, bone biochemical markers and bone mineral density in Chinese women aged 20-75

被引:91
作者
Liu, JM [1 ]
Zhao, HY
Ning, G
Zhao, YJ
Chen, Y
Zhang, LZ
Sun, LH
Xu, MY
Chen, JL
机构
[1] Shanghai Med Univ 2, Rui Jin Hosp, Dept Endocrine & Metab Dis, Shanghai 200025, Peoples R China
[2] Shanghai Inst Endocrine & Metab Dis, Shanghai 200025, Peoples R China
[3] Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai 200025, Peoples R China
关键词
OPG; RANKL; BMD;
D O I
10.1007/s00223-004-0007-2
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The correlations between the serum levels of OPG, RANKL with age, menopause, bone markers, and bone mineral densities (BMDs) at the lumbar spine and proximal femur were studied in 504 pre- and postmenopausal Chinese women aged 20 - 75 years. We found that age was positively and negatively correlated with serum concentrations of OPG ( r = 0.442, P < 0.001) and RANKL ( r =) 0.263, P < 0.001), respectively. Compared with premenopausal women, postmenopausal women showed higher serum OPG levels ( 107.6 +/- 3.0 vs 72.0 +/- 1.8 pg/ ml, P < 0.001), lower serum RANKL concentrations ( 4.7 +/- 0.4 vs. 5.8 +/- 0.3 pg/ ml, P < 0.001) and RANKL/OPG ratios ( 0.045 +/- 0.004 vs. 0.099 +/- 0.008, P < 0.001). Neither serum levels of OPG nor RANKL or RANKL/OPG ratio correlated with BMDs after adjustment of age and menopause. They also showed no differences among normal, osteopenic and osteoporotic postmenopausal women. Serum levels of OPG were positively correlated with urinary excretion of NTx ( r = 0.1453, P = 0.006). Serum levels of RANKL ( r =) 0.1928, P < 0.001) and RANKL/OPG ratio ( r =) 0.1303, P = 0.013) were inversely correlated with serum concentrations of OC. In multiple regression analysis, up to 20% variance (R-2 = 0.106 - 0.224) of the OPG-RANKL system in peripheral circulation can be explained by age, menopause and bone markers. These results suggest that although serum OPG and RANKL concentrations were unrelated with BMDs, the age - and menopause dependent changes of serum OPG and RANKL might be a protective mechanism against the accelerated bone loss in postmenopausal women.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 41 条
[1]
AKESSON K, 1995, J BONE MINER RES, V10, P1823
[2]
Serum osteoprotegerin and its ligand in Paget's disease of bone -: Relationship to disease activity and effect of treatment with bisphosphonates [J].
Alvarez, L ;
Peris, P ;
Guañabens, N ;
Vidal, S ;
Ros, I ;
Pons, F ;
Filella, X ;
Monegal, A ;
Muñoz-Gomez, J ;
Ballesta, AM .
ARTHRITIS AND RHEUMATISM, 2003, 48 (03) :824-828
[3]
The effect of a single dose of osteoprotegerin in postmenopausal women [J].
Bekker, PJ ;
Holloway, D ;
Nakanishi, A ;
Arrighi, M ;
Leese, PT ;
Dunstan, CR .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (02) :348-360
[4]
BER CE, 2002, CLIN ORTHOP RELAT R, V395, P174
[5]
Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women [J].
Browner, WS ;
Lui, LY ;
Cummings, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :631-637
[6]
Receptor activator for nuclear factor kappaB ligand and osteoprotegerin: regulators of bone physiology and immune responses/potential therapeutic agents and biochemical markers [J].
Buckley, KA ;
Fraser, WD .
ANNALS OF CLINICAL BIOCHEMISTRY, 2002, 39 :551-556
[7]
Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice [J].
Cao, J ;
Venton, L ;
Sakata, T ;
Halloran, BP .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (02) :270-277
[8]
Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): A pharmacodynamic and pharmacokinetic analysis in rats [J].
Capparelli, C ;
Morony, S ;
Warmington, K ;
Adamu, S ;
Lacey, D ;
Dunstan, CR ;
Stouch, B ;
Martin, S ;
Kostenuik, PJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (05) :852-858
[9]
Delmas PD, 2000, OSTEOPOROSIS INT, V11, P2, DOI 10.1007/s001980070002
[10]
DIEO ED, 1995, HORM METAB RES, V27, P151